Drug companies increasingly use medical science liaisons
The Wall Street Journal reports that drug companies are increasingly using medical science liaisons: ``Pharmaceutical companies are barred by the Food and Drug Administration from promoting unapproved drug uses, called off-label use, but they are using employees called 'medical science liaisons,' who are often physicians and pharmacists, as a legal way to discuss those uses.
72% of medicines management payers at Primary Care Trusts believe that GP consortia will develop their drug own formularies, a new poll has found.